The US drugmaker said on Monday that three doses of its children’s jab – each about a tenth of the size of an adult dose – produced a strong immune response with a favourable safety profile similar to a placebo in the age group.
An authorisation would open up the last large market for the Covid vaccine, potentially paving the way for a longer-term revenue stream if it became part of the childhood immunisation schedule. The Covid vaccine market has rapidly moved from shortage to glut in 2022 after pharmaceutical companies expanded production and the rollout of jabs in developing countries proved slower than expected., a health analytics company, cut its forecasts for sales of all Covid vaccines this year by 20 per cent to $64.1 billion.
But US parents have been among the most vocal about their desire to vaccinate the youngest children. Pfizer said the data would be shared this week with the US Food and Drug Administration, which is expected to consider whether to authorise the first Covid jabs for babies, toddlers and pre-school children next month.
Submissions to other regulatory authorities, including the EU, would follow shortly, said the company.
bessbell
IrishTimes 😂 the company said … No longer term data, recent data a concern in regards how testing was actioned for the adult version. No real transparency Kids not really at risk It’s already run through the population